Who owns the IMMPHENTIV trademark?

The IMMPHENTIV trademark is owned by Hikma Pharmaceuticals USA Inc..

What class is the IMMPHENTIV trademark registered in?

The IMMPHENTIV trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for IMMPHENTIV?

The USPTO serial number for IMMPHENTIV is 90432873.

What is the registration number for IMMPHENTIV?

IMMPHENTIV is registered under USPTO registration number 7754826.

Sealvo

Home Search: IMMPHENTIVIMMPHENTIV #90432873

Back

Updated Oct 3, 2026·34 searches this week

View on USPTO TSDR Find similar marks

IMM

USPTO Trademark Record

REGISTERED

IMMPHENTIV

SN 90432873·Reg 7754826·Filed Dec 30, 2020

Owner Hikma Pharmaceuticals USA Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

IMMPHENTIV (Serial No. 90432873), Registration No. 7754826, is a registered US trademark filed on Dec 30, 2020 by Hikma Pharmaceuticals USA Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: April 08, 2031

Conflict Analysis

Full conflict analysis for IMMPHENTIV (SN 90432873) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

IMMPHENTIV (Reg. #7754826) is a registered US trademark that has been protecting its owner, Hikma Pharmaceuticals USA Inc., since 2020. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 30, 2020

SERIAL

90432873

REG#

7754826

REGISTERED

Apr 08, 2025

Filing Information

StatusREGISTERED

Filing DateDec 30, 2020

Serial Number90432873

Registration No.7754826

Registration DateApr 08, 2025

Status DateApr 08, 2025

Published for OppositionAug 24, 2021

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Nov 22, 2023

First use in commerce: Nov 22, 2023

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

50 events

REGISTERED-PRINCIPAL REGISTER

Apr 08, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 08, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ASSIGNED TO LIE

Mar 19, 2025

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 19, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 19, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 19, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Mar 19, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 21, 2024

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 21, 2024

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Nov 21, 2024

TEAS CHANGE OF CORRESPONDENCE RECEIVED

ASSIGNED TO LIE

Jun 25, 2024

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jan 31, 2024

TEAS RESPONSE TO OFFICE ACTION RECEIVED

SU - NON-FINAL ACTION - WRITTEN

Jan 15, 2024

SU - NON-FINAL ACTION - WRITTEN

NON-FINAL ACTION E-MAILED

Jan 15, 2024

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jan 15, 2024

NOTIFICATION OF NON-FINAL ACTION E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Dec 09, 2023

CASE ASSIGNED TO INTENT TO USE PARALEGAL

STATEMENT OF USE PROCESSING COMPLETE

Dec 09, 2023

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

Nov 29, 2023

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

Nov 29, 2023

USE AMENDMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 14, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Oct 12, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Oct 12, 2023

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Oct 12, 2023

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 21, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 19, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Apr 19, 2023

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Apr 19, 2023

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 20, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Sep 18, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Sep 18, 2022

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Sep 18, 2022

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 14, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Apr 12, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Apr 12, 2022

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Apr 12, 2022

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 19, 2021

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 24, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 24, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 04, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Jul 22, 2021

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Jul 22, 2021

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Jul 22, 2021

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Jul 22, 2021

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 22, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

NON-FINAL ACTION WRITTEN

Jun 02, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Jun 02, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 02, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

May 29, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 25, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 02, 2021

NEW APPLICATION ENTERED

Other Marks by Hikma Pharmaceuticals USA Inc.

Additional USPTO filings from the same owner.

ENO

ENOBY

98089881

Hikma Pharmaceuticals USA Inc.

REGISTERED

XTR

XTRENBO

98091091

Hikma Pharmaceuticals USA Inc.

REGISTERED

STA

STARJEMZA

98140106

Hikma Pharmaceuticals USA Inc.

REGISTERED

STA

STARJEMZA

98140111

Hikma Pharmaceuticals USA Inc.

REGISTERED

Other Marks by Deborah L. Corpus

Additional USPTO filings handled by the same attorney of record.

ROY

ROYAL THAI

99089782

REGISTERED

UPT

UPTRIP

79437496

REGISTERED

EMD

EMDAC

76574637

REGISTERED

BEA

BEART

86200166

REGISTERED

IMMPHENTIV

Run a conflict check

Other Marks by Hikma Pharmaceuticals USA Inc.

Other Marks by Deborah L. Corpus

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company